FDA Approves Bimekizumab for Adults with Plaque Psoriasis
The approval for the IL-17A and IL-17F inhibitor is supported by data showing about 80% of patients achieved nearly clear skin within 4 doses.
Stay updated with breaking news from Published September. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The approval for the IL-17A and IL-17F inhibitor is supported by data showing about 80% of patients achieved nearly clear skin within 4 doses.
Read the latest stories and columns from staff writer Stephen Moore in The Washington Times.
Experts discuss how the change from starting mammography screening at age 40 instead of 50 will come with few benefits and big potential harms.
Patients who experience high levels of discrimination are more willing to participate in clinical trials, a new survey suggests.
Kenya Revenue Authority (KRA) will on Monday launch the Annual Taxpayer’s Month and unveil its online auction as well as the Tax Amnesty